Company overview
Xiamen Zeesan Biotech Co., Ltd.
USCC
91350200556210281J
Id2
350298200012016
English Name
Xiamen Zeesan Biotech Co., Ltd.
Former names
厦门致善生物科技有限公司
Chinese Name
厦门致善生物科技股份有限公司
Entity type
Joint Stock Company (Non-Listed, Natural Person Invested or Controlled)
Authorized capital
¥4,500
IR@zsandx.com
Phone
+865927290796
Representative
李庆阁 (Li Qing Ge)
Establishment date
12 June 2010
Country
China
Primary goods traded
- 76.7% — 382200 (382200)
- 11.0% — 902780 (902780)
- 5.0% — Reagents (382290)
- 3.8% — Machines and mechanical appliances (847989)
- 3.5% — Prepared culture media for the development or maintenance of micro-organisms (including viruses and the like) or of plant, human or animal cells (382100)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Setia Anugrah Medika | buyer | $5,823,468 | 72.74% |
| PT Sinergi Indomitra Pratama | buyer | $1,356,750 | 16.95% |
| PT Trinisyah Ersa Pratama | buyer | $733,563 | 9.16% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 6 May 2020 | ID | 38220090 | Virus Rna Extraction Kit | PT Sinergi Indomitra Pratama | ID | Xiamen Zeesan Biotech Company Limited | CN | $452,250.00 |
| 28 April 2020 | ID | 38220090 | Virus Rna Extraction Kit | PT Sinergi Indomitra Pratama | ID | Xiamen Zeesan Biotech Company Limited | CN | $452,250.00 |
| 6 May 2020 | ID | 38220090 | Virus Rna Extraction Kit | PT Sinergi Indomitra Pratama | ID | Xiamen Zeesan Biotech Company Limited | CN | $452,250.00 |
| 24 February 2022 | ID | 38220090 | - Sars-Cov-2 Test Kit(liquid) | PT Setia Anugerah Medika | ID | Xiamen Zeesan Biotech Company Limited | CN | $259,200.00 |
| 22 September 2021 | ID | 38220090 | Sars Cov - 2 Test Kit ( Liquid ) | PT Setia Anugerah Medika | ID | Xiamen Zeesan Biotech Company Limited | CN | $233,124.56 |
| 9 August 2021 | ID | 38220090 | Sars Cov - 2 Test Kit ( Liquid ) | PT Setia Anugerah Medika | ID | Xiamen Zeesan Biotech Company Limited | CN | $233,123.28 |
| 27 October 2021 | ID | 38220090 | Sars-Cov-2 Test Kit (Liquid) | PT Setia Anugerah Medika | ID | Xiamen Zeesan Biotech Company Limited | CN | $194,488.84 |
| 2 March 2022 | ID | 38220090 | Zeesan-Sars-Cov-2 Test Kit (Real Time Pcr) | PT Setia Anugerah Medika | ID | Xiamen Zeesan Biotech Company Limited | CN | $175,262.83 |
| 2 February 2022 | ID | 38220090 | Sars-Cov-2 Test Kit | PT Setia Anugerah Medika | ID | Xiamen Zeesan Biotech Company Limited | CN | $175,201.26 |
| 23 November 2021 | ID | 38220090 | Zeesan Sars-Cov-2 Test Kit (Liquid) | PT Setia Anugerah Medika | ID | Xiamen Zeesan Biotech Company Limited | $175,163.47 |
0 of 20 row(s) selected.